ANDRÉS
ÍÑIGUEZ ROMO
Investigador hasta 2007
Imperial College London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Imperial College London (10)
2023
-
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial
International Journal of Cardiology, Vol. 391
-
Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)
American Journal of Cardiology, Vol. 190, pp. 32-40
2022
-
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
American Heart Journal, Vol. 246, pp. 32-43
-
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study
European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316
-
Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial
Journal of the American Heart Association, Vol. 11, Núm. 23
-
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial
JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973
2019
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study
EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252
-
Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial
Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925
2017
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134
-
Evolocumab and clinical outcomes in patients with cardiovascular disease
New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722